AI assistant
Sending…
Moderna, Inc. — Director's Dealing 2022
Sep 9, 2022
30610_dirs_2022-09-09_b05bc4f9-dc89-4225-b8c5-04cdb10810e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2022-09-06
Reporting Person: Mock James M (Chief Financial Officer)
More from Moderna, Inc.
Regulatory Filings
2026
May 11
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 23
Annual Report
2026
Feb 20
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 13